Skip to main content
Clinical Trials/ACTRN12610000522011
ACTRN12610000522011
Completed
未知

A randomised, controlled crossover trial of the effect of high concentration oxygen on transcutaneous carbon dioxide tension in obese hospitalised patients.

Medical Research Institute of New Zealand0 sites48 target enrollmentJune 24, 2010

Overview

Phase
未知
Intervention
Not specified
Conditions
Hypercapnia as a consequence of oxygen therapy in obese individuals.
Sponsor
Medical Research Institute of New Zealand
Enrollment
48
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 24, 2010
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Current internal medicine inpatient in Wellington Hospital; 2\. Age \>/\= 16 years; 3\. Body Mass Index (BMI) \> 40kg/m2\.

Exclusion Criteria

  • 1\. Diagnosis of Chronic Obstructive Pulmonary Disease (COPD); 2\. Ratio of Forced Expiratory Volume in one second to Forced Vital Capacity (FEV1:FVC) \< 0\.7 (First 24 participants recruited only); 3\. Patients currently receiving treatment with Continuous Positive Airway Pressure (CPAP) ventilation or Non\-Invasive Positive Pressure Ventilation (NIPPV); 4\. Patients currently requiring \>2L/minute of oxygen therapy following titration to the recommended target saturation range of 88\-92% (First 24 participants recruited only); 5\. Patients with baseline PtCO2 of \>65mmHg; 6\. Current diagnosis of disease causing restriction to chest wall expansion, other than obesity i.e. neuromuscular disease or chest wall dysfunction; 7\. Administration of respiratory suppressant medications, including opiate analgesia and benzodiazepines within 24 hours (First 24 participants recruited only); 8\. Patients with unstable angina or recent myocardial infarction.

Outcomes

Primary Outcomes

Not specified

Similar Trials